Early supported discharge after stroke in Bergen (ESD Stroke Bergen): three and six months results of a randomised controlled trial comparing two early supported discharge schemes with treatment as usual

Table 3 Percentage of patients independent (BI ≥ 95 or mRS ≤ 2) and dependent (BI < 95 or mRS > 2) at baseline and after 3 and 6 months in the ESD arms combined and in the control arm; mRS and mRS change scores at 3 and 6 months in 306 ESD Stroke Bergen study patients

Time	ESD arms (1 + 2)	Control arm	p-value*
Baseline
BI ≥ 95; n/N (%)	108/206 (52.4)	51/98 (52.0)	0.950
mRS ≤ 2; n/N (%)	109/207 (52.7)	49/99 (49.5)	0.605
3 months
BI ≥ 95; n/N (%)	113/164 (68.9)	42/67 (62.7)	0.362
mRS ≤ 2; n/N (%)	93/171 (54.4)	30/71 (42.3)	0.086
mRS; mean (SD)	2.37 (1.41)	2.62 (1.40)	0.204
mRS change score 0–3 months; mean (SD)	−0.31 (1.08)	0 (1.07)	0.049
6 months
BI ≥ 95; n/N (%)	111/153 (72.5)	40/60 (66.7)	0.395
mRS ≤ 2; n/N (%)	90/163 (55.2)	29/66 (43.9)	0.122
mRS; mean (SD)	2.43 (1.49)	2.73 (1.52)	0.188
mRS change score 0–6 months; mean (SD)	−0.21 (1.22)	0 (1.19)	0.319

Abbreviations: BI Barthel Index, mRS Modified Rankin Scale, ESD Early Supported Discharge, SD Standard Deviation.
*Statistical tests: χ2-test (analyses of dichotomised BI and mRS) and Mann–Whitney U-test (mRS and mRS change score), p-value <0.05 indicated in bold.

ISSN: 1471-2377